97/100
High Financial Strength
16/100
Expensive Valuation
53/100
Technically Neutral
Strength
13
Weakness
4
Opportunity
1
Threats
0
Market Cap (Cr)
PE Ratio
Price to Book Ratio
RSI
Net Profit Margin
Closure of Trading Window
Intimation of the Closure of Trading Window
Announcement under Regulation 30 (LODR)-Issue of Securities
Intimation regarding Issue of Commercial Papers
Redemption Of Commercial Paper Issued Under ISIN INE685A14112
Redemption of Commercial paper issued under ISIN iINE685A14112
Announcement under Regulation 30 (LODR)-Issue of Securities
Intimation regarding issuance of Commercial Papers
Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under regulation 30 of SEBI Listing Regulations
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating
Clarification / Information On News Item
Clarification / Information on news item
Clarification sought from Torrent Pharmaceuticals Ltd
The Exchange has sought clarification from Torrent Pharmaceuticals Ltd with reference to news appeared on https://economictimes.indiatimes.com dated August 13 2024 (Link:... More>
Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2024
Shareholder Meeting / Postal Ballot-Scrutinizers Report
Declaration of Voting Results
Results
Results Q1 FY 2024-25.
Announcement under Regulation 30 (LODR)-Cessation
Intimation of Cessation.
Board Meeting Outcome for Outcome Of Board Meeting Dated 23-07-2024
Outcome of Board Meeting Dated 23-07-2024.
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of 51st AGM held on 23-07-2024.
Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel.
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post Quarterly Financial Result Conference call with investors / analyst
Board Meeting Intimation for Consider And Approve The Audited Financial Results On Standalone Basis
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Tuesday ... More>
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cuttings in connection with the 51st Annual General Meeting and E-Voting Procedure.
Submission Of The Annual Report For The FY 2023-24 And The Notice Convening 51St Annual General Meet
Submission of the Annual Report for the FY 2023-24 and the Notice convening 51st AGM of the Company
Reg. 34 (1) Annual Report.
Submission of Annual Report for FY 2023-24 and intimation of voting through electronic means
Business Responsibility and Sustainability Reporting (BRSR)
Submission of the Business Responsibility and Sustainability Report (BRSR) for FY 2023-24 of the Company
Closure of Trading Window
Intimation of the Closure of Trading Window as per Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Intimation of the 51st Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means (VC / OAVM) facility
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Intimation under regulation 30 of SEBI (LODR) regulation 2015
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference Call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of Newspaper cuttings in connection with transfer of shares to IEPF.
Board Meeting Outcome for Outcome Of Board Meeting Dated 24-May-24
Outcome of Board meeting dated 24-May-24
Announcement under Regulation 30 (LODR)-Resignation of Director
In continuation to our earlier letter dated 24-May-24 intimating the desire of Jinesh Shah to step down as the Director of the Company effective from 23-Jul-24 please find the letter attached herewith received from Jinesh Shah as Annexure 1 in this respect
Record Date Intimation
Record date intimation for Final Dividend for the year 2023-24
Announcement under Regulation 30 (LODR)-Raising of Funds
Raising of funds
Announcement under Regulation 30 (LODR)-Date of payment of Dividend
Date of payment of final dividend for the year 2023-24
Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Directorate
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company... More>
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend updates
Announcement under Regulation 30 (LODR)-Raising of Funds
Raising of funds
Results
Results
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation
Corporate Action-Board approves Dividend
Dividend Updates
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of share certificate
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31-Mar-24
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post Quarterly Financial Result Conference call with investors / analyst
Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve We would like to inform you that: 1. A meeting of the Board of Directors will be held on Friday... More>
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (Listing Obligation and disclosure Requirements) Regulations 2015
Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015
Compliance Certificate u/r 40(9) of SEBI (LODR) Regulations 2015
Conclusion Time Of The 50Th Annual General Meeting Of The Company
Conclusion time of the 50th Annual General Meeting of the Company
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure u/r 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosu
Compliance Certificate under Regulation 7(3)
Announcement under Regulation 30 (LODR)-Cessation
Intimation of Cessation of Directors of the Company
Announcement under Regulation 30 (LODR)-Retirement
Intimation of Cessation of Directors of Company
Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of Cessation of Directors of the Company
Closure of Trading Window
Intimation of the Closure of Trading Window
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificates
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat
Intimation u/r 30 of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Audio Recording Of Con-Call With Analyst / Investor On Financial Result For Quarter And Nine Months
Audio recording
Announcement under Regulation 30 (LODR)-Date of payment of Dividend
Date of payment of dividend
Corporate Action-Board approves Dividend
Dividend update
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend update
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation
Board Meeting Outcome for Bm Outcome
BM outcome
Financial Result - Q3 2023-24
Result
Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regul
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mehta Family Trust 1 & Others & PACs
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mehta Family Trust 1 & Others & PACs
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mehta Family Trust & PACs
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mehta Family Trust & PACs
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post Quarterly Financial Result Conference call with investors / analyst
Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regul
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Corporate Action-Board to consider Dividend
Intimation of Record Date pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Friday 02-Feb-24... More>
